(19) |
 |
|
(11) |
EP 1 201 236 A8 |
(12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
published in accordance with Art. 158(3) EPC |
(48) |
Corrigendum issued on: |
|
09.10.2002 Bulletin 2002/41 |
(43) |
Date of publication: |
|
02.05.2002 Bulletin 2002/18 |
(22) |
Date of filing: 28.06.2000 |
|
(86) |
International application number: |
|
PCT/JP0004/286 |
(87) |
International publication number: |
|
WO 0100/1978 (11.01.2001 Gazette 2001/02) |
|
(84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
Designated Extension States: |
|
AL LT LV MK RO SI |
(30) |
Priority: |
30.06.1999 JP 18529799
|
(71) |
Applicants: |
|
- Mitsubishi Pharma Corporation
Osaka-shi, Osaka 541-0046 (JP)
- Matsumori, Akira
Minoh-shi, Osaka 562-0045 (JP)
|
|
(72) |
Inventor: |
|
- MATSUMORI, Akira
Minoh-shi, Osaka 562-0045 (JP)
|
(74) |
Representative: von Kreisler, Alek, Dipl.-Chem. et al |
|
Patentanwälte von Kreisler-Selting-Werner Postfach 10 22 41 50462 Köln 50462 Köln (DE) |
|
|
|
(54) |
MEDICINAL COMPOSITIONS FOR PREVENTING OR TREATING VIRAL MYOCARDITIS |
(57) The present invention aims at providing a pharmaceutical composition for the prophylaxis
or treatment, irrespective of the kind of virus, of viral myocarditis or-viral diseases
induced by viral myocarditis, by the treatment or prevention of the onset of cytotoxicity
in various organs, and a method of the prophylaxis or treatment. The present invention
also relates to a pharmaceutical composition for the prophylaxis or treatment of viral
myocarditis or viral diseases induced by viral myocarditis, which contains 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol
or a pharmacologically acceptable salt thereof as an active ingredient. The present
invention further relates to a method for the prophylaxis or treatment of viral myocarditis
or viral diseases induced by viral myocarditis, which includes administering an effective
amount of the aforementioned compound or a pharmacologically acceptable salt thereof.